HSBC Holdings
TMCI icon

HSBC Holdings’s Treace Medical Concepts TMCI Stock Holding History

HSBC Holdings’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.4K Buy
30,994
+6,554
+27% +$13.1K ﹤0.01% 2821
2025
Q4 		$59.9K Buy
+24,440
New +$106K ﹤0.01% 2850
2025
Q3 		– Sell
-16,882
Closed -$98.1K – 3129
2025
Q2 		$98.1K Buy
16,882
+6,144
+57% +$40K ﹤0.01% 2858
2025
Q1 		$88.9K Buy
+10,738
New +$96.5K ﹤0.01% 2831
2024
Q1 		– Sell
-10,127
Closed -$128K – 3237
2023
Q4 		$128K Buy
+10,127
New +$102K ﹤0.01% 2557
2022
Q3 		– Sell
-10,233
Closed -$149K – 3262
2022
Q2 		$149K Sell
10,233
-2,386
-19% -$40.2K ﹤0.01% 2956
2022
Q1 		$239K Sell
12,619
-2,247
-15% -$43.7K ﹤0.01% 2901
2021
Q4 		$275K Buy
+14,866
New +$307K ﹤0.01% 2840

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's TMCI Position: Q1 2026 in Review

HSBC Holdings increased its Treace Medical Concepts (TMCI) stake by 27% in Q1 2026, buying an estimated $13.1K and bringing the position to 30,994 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2821.

HSBC Holdings first reported a position in TMCI in Q4 2021 and has held it in 8 quarters since. The position peaked at $275K in Q4 2021. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • HSBC Holdings held 30,994 shares of Treace Medical Concepts worth $40.4K as of Q1 2026.
  • HSBC Holdings bought 6,554 Treace Medical Concepts shares in Q1 2026, an estimated $13.1K.
  • Treace Medical Concepts made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2821 holding.
  • HSBC Holdings first reported a position in Treace Medical Concepts in Q4 2021 and has held it in 8 quarters since.
  • HSBC Holdings's Treace Medical Concepts position peaked at $275K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.